MANDY METZGER: Open Payments
NPI 1376735126 · BURBANK, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,966 in 82 payments from 15 companies in 2025. Trend: 2023 $1,384 · 2024 $2,035 · 2025 $1,966
Food & beverage: $1,966
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 44 | $1,028 |
| PFIZER INC. | 9 | $200 |
| Neurelis, Inc. | 4 | $137 |
| UCB, Inc. | 4 | $107 |
| SK Life Science, Inc. | 3 | $72 |
| Janssen Biotech, Inc. | 2 | $60 |
| Eisai Inc. | 2 | $59 |
| Genentech USA, Inc. | 2 | $54 |
| Cycle Pharmaceuticals Inc | 2 | $47 |
| SCILEX PHARMACEUTICALS INC. | 3 | $47 |
Products named: UBRELVY, QULIPTA, NURTEC ODT, BOTOX, VALTOCO, Leqembi, Ocrevus Zunovo, VYEPTI.
Industry payments across CA — which companies pay providers there.
